| NMOSD with SCA (n = 23) | NMOSD without SCA (n = 162) | P |
---|---|---|---|
Brain lesions, n (%) | |||
 Brain lobes | 15 (65.2%) | 71 (46.5%) | 0.054 |
 Basal ganglia | 5 (21.7%) | 26 (16%) | 0.494 |
 Hypothalamic and thalamic | 6 (26.1%) | 19 (11.7%) | 0.059 |
 Medulla oblongata | 8 (34.8%) | 31 (19.1%) | 0.085 |
 Pons | 8 (34.8%) | 32 (19.8%) | 0.101 |
 Mesencephalon | 2 (8.7%) | 6 (4.3%) | 0.271 |
 Peri-ventricleand peri-aqueduct | 7 (30.4%) | 35 (21.6%) | 0.344 |
 Cerebellum | 3 (13%) | 8 (4.9%) | 0.124 |
Spinal cord lesions, n (%) | Â | Â | Â |
Cervical cord | 20 (87%) | 79 (48.4%) | 0.001** |
Segments lesions | 4.74 ± 1.91 | 4.65 ± 1.87 | 0.849 |
LETM | 13 (56.5%) | 62 (59%) | 0.842 |
STM | 10(43.5%) | 32 (30.5%) | 0.229 |
Thoracic cord | 3 (13%) | 62 (38.3%) | 0.018* |
Segments lesions | 6.00 ± 3.37 | 5.53 ± 2.93 | 0.549 |
LETM | 18 (73.9%) | 67 (65.7%) | 0.448 |
STM | 6 (26.1%) | 26 (24.8%) | 0.894 |
Cervical and thoracic cord | 17 (73.9%) | 45 (27.8%) | 0.001** |